VirTra, Inc. (NASDAQ:VTSI – Get Rating)’s share price fell 4.7% during mid-day trading on Monday . The stock traded as low as $4.83 and last traded at $4.83. 15,881 shares changed hands during mid-day trading, an increase of 36% from the average session volume of 11,658 shares. The stock had previously closed at $5.07.
VirTra Stock Down 2.6 %
The firm’s 50-day moving average price is $4.64 and its 200-day moving average price is $5.06. The company has a market cap of $52.04 million, a price-to-earnings ratio of 98.20, a price-to-earnings-growth ratio of 0.92 and a beta of 0.70. The company has a debt-to-equity ratio of 0.25, a current ratio of 4.76 and a quick ratio of 3.33.
VirTra (NASDAQ:VTSI – Get Rating) last released its quarterly earnings data on Monday, November 14th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.08). VirTra had a return on equity of 1.79% and a net margin of 2.03%. The business had revenue of $4.90 million during the quarter, compared to analyst estimates of $5.33 million. Sell-side analysts forecast that VirTra, Inc. will post 0.08 earnings per share for the current fiscal year.
Institutional Investors Weigh In On VirTra
About VirTra
VirTra, Inc provides force training simulators and firearms training simulators for law enforcement, military, educational, and commercial markets worldwide. It offers V-300 simulator, a 300 degree wrap-around screen for simulation training; V-180 simulator, a 180 degree screen for smaller spaces or budgets; V-100, a single-screen firearms training simulator system; V-100 MIL, a single-screen small arms training simulator; and V-ST PRO, a realistic single screen firearms shooting and skills training simulator.
Read More
- Get a free copy of the StockNews.com research report on VirTra (VTSI)
- Union Pacific, Norfolk Southern Pull into Buying Zone
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
Receive News & Ratings for VirTra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VirTra and related companies with MarketBeat.com's FREE daily email newsletter.